Biostatiq ApS: Financial statements 2022
CVR: 40966285
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Biostatiq ApS (CVR 40966285) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 102,093 and a net result of DKK 73,467 compared with DKK -21,255 the year before. Equity in the 2022 report amounted to DKK 57,934. The solvency ratio was 55.3%.
- Gross Profit
- DKK 102,093
- Profit/Loss
- DKK 73,467
- Equity
- DKK 57,934
- Total Assets
- DKK 104,714
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 102 t. | 73 t. | 58 t. | 0 |
| 2021 | - | -8 t. | -21 t. | -16 t. | 0 |
Official annual report
Keep an eye on Biostatiq ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of December 20, 2022, AAEN & CO. STATSAUTORISEREDE REVISORER P/S has stepped down as auditor of Biostatiq ApS.
As of December 20, 2022, Carsten Dan Petersen has stepped down as director of Biostatiq ApS.
As of November 15, 2022, Frank Friis Nielsen is registered as an owner of Biostatiq ApS with an ownership share of 66%.
Biostatiq ApS has published its annual report for 2021. Gross profit came to DKK -7,500, and the net result was DKK -21,255.
About Biostatiq ApS
Biostatiq ApS is a Danish company of the type Anpartsselskab based in Gilleleje, founded in 2019. The company is registered under the industry Fremstilling af andet elektrisk udstyr. The company was previously named Stealth Induction ApS. The management consists of Carsten Dan Petersen. The company is owned by Frank Friis Nielsen and Arkenstone Capital ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK 808,404 and a net result of DKK 247,002 compared with DKK -4,883 the year before. Equity in the 2025 report amounted to DKK 299,178.